Kishan Reddy inspects Gandhi Hospital, calls for upgrading facilities
During the inspection, the minister interacted with the hospital Superintendent and staff, seeking details about patient amenities, departmental preparedness, and the status of key medical infrastructure. He also visited the oxygen plants installed during the COVID-19 pandemic, which continue to remain operational.
Speaking to the media after the visit, the Union Minister said, 'Gandhi Hospital is the largest government healthcare facility in the Secunderabad Parliamentary constituency, which I represent. I visited to assess the facilities available to patients and to ensure that the hospital is equipped to handle increasing patient loads. With COVID-positive cases rising again, hospital staff must remain vigilant, and the public should be reminded to follow safety protocols,' he added.
'There is an urgent requirement to fill the vacant Resident Medical Officer (RMO) posts and to operationalise newly sanctioned departments,' he said.
The minister also highlighted the implementation of the Ayushman Bharat health insurance scheme, under which patients are being issued Aadhaar-linked health cards. 'These cards enable beneficiaries to access free treatment not just at Gandhi Hospital, but at other empanelled hospitals as well,' he said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
26 minutes ago
- Hindustan Times
No change in blood donation rules for transpersons: Govt
NEW DELHI The Supreme Court building in New Delhi. (HT Photo) The Union government has told the Supreme Court that there is no need to revise the existing blood transfusion policy prohibiting donation from transgender persons, men having sex with men (MSM) and women sex workers, underlining that these groups continue to present a statistically higher risk of HIV and other transfusion-transmitted infections. 'Allowing blood donations from individuals statistically linked with a higher prevalence of TTIs (transfusion-transmitted infections) would proportionately increase systemic risks and undermine the integrity and reliability of the national blood supply chain… No modification or relaxation of the guidelines is warranted at this time,' said an affidavit by the ministry of health and family welfare filed before a bench led by justice Surya Kant. Maintaining that the deferment of individuals belonging to high-risk categories is both 'reasonable and essential', the affidavit added: 'These guidelines are firmly rooted in globally accepted scientific research, established public health principles, and robust epidemiological evidence. Any dilution or relaxation of these standards would pose a serious risk to the safety and integrity of the national blood supply.' The affidavit was filed in response to the court's oral suggestion in May that the policy be reconsidered in light of medical advancements and evolving global practices. Acting on the court's direction, the Directorate General of Health Services set up an expert committee, which met on May 29 and concluded that no change was warranted in the 2017 Guidelines for Blood Donor Selection and Referral. The expert panel highlighted that even the most advanced testing technologies cannot offer absolute assurance of detecting infections during the 'window period' when diseases like HIV remain undetectable. In such circumstances, exclusion of high-risk groups was described as a 'prudent, precautionary, and evidence-based measure' aligned with international standards. 'Notwithstanding the availability of modern testing technologies, no diagnostic test can offer a 100% guarantee of detecting all infections, particularly during the 'window period,' wherein certain infections may remain undetectable,' stated the affidavit, adding that due to such inherent limitations, the exclusion of high-risk categories continues to be a 'prudent, precautionary, and evidence-based measure'. Pointing to epidemiology, the Centre said the challenged clauses rest on data, not stigma. 'Multiple international research studies have consistently highlighted a significantly high prevalence of HIV and other sexually transmitted infections among transgender persons, particularly transgender women… Accordingly, the deferment… is rooted in established epidemiological data and public health evidence, which reflect a higher incidence of TTIs, notably HIV, within such population groups,' it said. The government also noted that while some Western countries have lifted restrictions on certain donor categories, many Asian neighbours, including Sri Lanka, Thailand, Indonesia, the Philippines, Malaysia, Singapore and China, continue to uphold similar bans. India, it said, must base its policies on its own epidemiological profile, health care infrastructure and diagnostic capacities. Invoking constitutional obligations, the Centre framed the policy as a precaution the Constitution demands. 'The continued adherence to the precautionary principle in matters relating to blood safety is not only justified but also constitutionally mandated under the State's obligation to protect public health, as enshrined in Article 47 of the Constitution of India,' the affidavit asserted. The affidavit comes after the Supreme Court, during a hearing on May 14, questioned the rationale of branding entire communities as 'risky' donors. The bench had asked: 'Are we going to brand all transgenders as risky and stigmatise them? You cannot say that all transgenders are indulging in sexual activity.' The court had observed that transgenders already face severe prejudice and warned against creating 'a segregated group' that would deepen stigma. The petitions, including one filed by Manipur-based transgender activist Thangjam Santa Singh in 2021, have challenged some relevant clauses of the 2017 guidelines, arguing that they are unconstitutional as they discriminate on the basis of gender identity and sexual orientation. The plea asserts that the exclusions perpetuate stereotypes and violate the right to equality under Articles 14 and 15 of the Constitution.
Time of India
38 minutes ago
- Time of India
Facility to test, quarantine & treat passengers at Cial soon
Kochi: Chief minister Pinarayi Vijayan will inaugurate a health facility at Cochin International Airport Ltd (Cial) on Saturday. The facility, with World Health Organization (WHO) recognition, will be where passengers suffering from communicable diseases like Covid, which originate from other countries can be quarantined, tested and treated on the airport premises itself. Tired of too many ads? go ad free now "We constructed a 33,000 sqft building to house the health centre. Kochi will be the third airport with such a facility, after Delhi and Mumbai," said a Cial official. The hospital will not only provide treatment to passengers reaching Kochi but also help avoid complications of tracking such patients after they get out of the airport and travel across the state and country. Airport Health Organization (AHO), Cochin, a subordinate office of ministry of health and family welfare, will operate the facility. It is already functioning as a designated yellow fever vaccination centre and serves as the health screening unit at Cial. AHO acts as the first line of health surveillance for all international passengers arriving in Kerala, making it a vital part of the public health defence system. The facility will have a state-of-the-art quarantine centre with seven negative-pressure quarantine rooms, including two VIP units. The centre is designed to ensure that any passenger suspected of carrying infectious diseases can be safely isolated without disrupting routine airport operations. The flexibility to dedicate an entire floor with separate access, if required, reflects the adaptability of this infrastructure, said the official. The facility will have dedicated parking space for mobile testing laboratories, thus allowing rapid response with minimal inconvenience to the public. Tired of too many ads? go ad free now Also, the establishment of a fully equipped vector surveillance and field laboratory on the second floor will strengthen the ability to monitor, detect and prevent vector-borne diseases even before the passengers from outside reach Kochi. This facility not only addresses current challenges but also provides scope for future expansion, including upgrading biosafety levels later, the official added. "Cial is one of the busiest gateways to our state besides being a crucial hub for international travel and trade. Each day, thousands of passengers arrive here, many of them our own non-resident Keralites returning from the Middle East. While this connectivity enriches Kerala, it also brings with it the responsibility of protecting against the importation and exportation of diseases of global concern. In recent years, Kerala faced multiple outbreaks —from Nipah to Covid-19— and each time, our state demonstrated resilience and determination. But these experiences also underscored the urgent need to strengthen our preparedness at critical entry points. And in this mission, AHO, Cochin's role is truly vital," said a top Cial official.
Economic Times
2 hours ago
- Economic Times
Fortis Healthcare still heals portfolios, but valuations are running hot.
Covid took away millions of lives, but it also brought to light one segment that may be worth investing in — hospitals. With no major chain other than Apollo Hospitals a decade ago, analysts paid little attention to the segment. Even after the pandemic changed that, Fortis Healthcare Ltd. was a laggard, thanks to charges of malpractices of its ousted promoters. That hangover seems to be receding. Fortis Healthcare stock is up 80% in the past
